Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silver Range Resources: A hidden gem in the mining industry (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medx Health Corp V.MDX

Alternate Symbol(s):  MDXHF

Healthcare Medical Devices
MedX Health Corp. is a medical device and software company. It develops and manufactures skin-related screening tools and phototherapy devices for pain relief and tissue repair. It focuses on skin health with its SIAscopy on DermSecure telemedicine platform, utilizing its SIAscopy technology. SIAscopy is a medical device technology that is used to scan skin for suspicious moles and lesions and, including DermSecure, its telemedicine software application, and phototherapeutic medical devices, which use light energy in lower-level laser and light-emitting diode to provide treatment of pain and tissue damage in the rehabilitation market. Its products SIAMETRICS, SIMSYS, and MoleMate include hand-held devices that use technology utilizing light and its remittance to view suspicious moles and lesions up to two millimeters (mm) beneath in a pain-free, non-invasive manner. Its SIAscopy on DermSecure telemedicine platform enables the Web-based operation of its SIAscopy scanning technology.


TSXV:MDX - Post by User

Medx Health Corp > Chris Thompson Research calls for revenue breakout in 2021
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(13)
•••
Comment by Bully88on Dec 16, 2020 10:13am
121 Views
Post# 32117919

RE:RE:RE:Chris Thompson Research calls for revenue breakout in 2021

RE:RE:RE:Chris Thompson Research calls for revenue breakout in 2021I definitely agree that MDX is at a point with investors of "show me the money".

I believe that at this point, the showing of the money is right around this corner, and we have all seen the lows and this company from this point will contiune to show increased revenue Q/Q and will become very profitable in 2021.

I am on the same boat as many here that have been waiting for years and it finally seems to be turning the corner.

Hold strong and your patience will be rewarded.

once momentum gains traction here it will carry on long term with continued growth of interest.

The netherlands revenue is just the beginning.

Cheers, 

Bully
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities